- Home
- AUPH vs GAM Comparison
AUPH vs GAM Comparison
Compare AUPH & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- GAM
- Stock Information
- Founded
- AUPH 1993
- GAM 1927
- Country
- AUPH Canada
- GAM United States
- Employees
- AUPH N/A
- GAM N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- GAM Investment Managers
- Sector
- AUPH Health Care
- GAM Finance
- Exchange
- AUPH Nasdaq
- GAM Nasdaq
- Market Cap
- AUPH 999.8M
- GAM 1.2B
- IPO Year
- AUPH 1999
- GAM N/A
- Fundamental
- Price
- AUPH $8.09
- GAM $49.54
- Analyst Decision
- AUPH Strong Buy
- GAM
- Analyst Count
- AUPH 2
- GAM 0
- Target Price
- AUPH $11.50
- GAM N/A
- AVG Volume (30 Days)
- AUPH 1.3M
- GAM 20.1K
- Earning Date
- AUPH 05-05-2025
- GAM 01-01-0001
- Dividend Yield
- AUPH N/A
- GAM 5.74%
- EPS Growth
- AUPH N/A
- GAM N/A
- EPS
- AUPH 0.04
- GAM 11.67
- Revenue
- AUPH $235,133,000.00
- GAM N/A
- Revenue This Year
- AUPH $11.86
- GAM N/A
- Revenue Next Year
- AUPH $24.96
- GAM N/A
- P/E Ratio
- AUPH $197.25
- GAM $3.95
- Revenue Growth
- AUPH 33.97
- GAM N/A
- 52 Week Low
- AUPH $4.77
- GAM $37.32
- 52 Week High
- AUPH $10.67
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- AUPH 54.42
- GAM 51.05
- Support Level
- AUPH $7.59
- GAM $47.49
- Resistance Level
- AUPH $7.83
- GAM $50.56
- Average True Range (ATR)
- AUPH 0.34
- GAM 1.94
- MACD
- AUPH 0.04
- GAM 0.12
- Stochastic Oscillator
- AUPH 84.90
- GAM 88.36
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.